Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Final Outcomes from the Randomized RECOVERY Trial of Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy
Ophthalmol Retina 2022 Jul 01;6(7)557-566, CC Wykoff, MG Nittala, C Villanueva Boone, HJ Yu, W Fan, SB Velaga, JP Ehlers, MS Ip, SR SaddaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.